Clinical trial
A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)
NCT00175747 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00175747 |
|---|---|
| Title | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) |
| Official title | A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People With Dysplasia of the Bronchial Epithelium |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Inhaled Budesonide 800 µg twice daily |
| Enrollment | 120 |
| Start date | Jan 1, 2000 |
| Completion | Dec 1, 2002 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: